PortfoliosLab logo
CVS vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CVS and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

CVS vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CVS Health Corporation (CVS) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%1,000.00%December2025FebruaryMarchAprilMay
87.69%
834.89%
CVS
ABBV

Key characteristics

Sharpe Ratio

CVS:

0.10

ABBV:

0.98

Sortino Ratio

CVS:

0.44

ABBV:

1.35

Omega Ratio

CVS:

1.06

ABBV:

1.21

Calmar Ratio

CVS:

0.07

ABBV:

1.28

Martin Ratio

CVS:

0.34

ABBV:

3.19

Ulcer Index

CVS:

12.49%

ABBV:

8.31%

Daily Std Dev

CVS:

37.81%

ABBV:

27.09%

Max Drawdown

CVS:

-64.07%

ABBV:

-45.09%

Current Drawdown

CVS:

-31.88%

ABBV:

-7.55%

Fundamentals

Market Cap

CVS:

$84.21B

ABBV:

$342.01B

EPS

CVS:

$3.66

ABBV:

$2.34

PE Ratio

CVS:

18.23

ABBV:

82.62

PEG Ratio

CVS:

0.67

ABBV:

0.41

PS Ratio

CVS:

0.23

ABBV:

5.97

PB Ratio

CVS:

1.09

ABBV:

102.95

Total Revenue (TTM)

CVS:

$378.96B

ABBV:

$57.37B

Gross Profit (TTM)

CVS:

$53.24B

ABBV:

$46.58B

EBITDA (TTM)

CVS:

$13.64B

ABBV:

$16.33B

Returns By Period

In the year-to-date period, CVS achieves a 53.76% return, which is significantly higher than ABBV's 13.78% return. Over the past 10 years, CVS has underperformed ABBV with an annualized return of -0.95%, while ABBV has yielded a comparatively higher 16.82% annualized return.


CVS

YTD

53.76%

1M

0.13%

6M

23.67%

1Y

27.98%

5Y*

5.80%

10Y*

-0.95%

ABBV

YTD

13.78%

1M

-2.38%

6M

-0.67%

1Y

27.91%

5Y*

24.14%

10Y*

16.82%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CVS vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CVS
The Risk-Adjusted Performance Rank of CVS is 5454
Overall Rank
The Sharpe Ratio Rank of CVS is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of CVS is 5050
Sortino Ratio Rank
The Omega Ratio Rank of CVS is 5151
Omega Ratio Rank
The Calmar Ratio Rank of CVS is 5656
Calmar Ratio Rank
The Martin Ratio Rank of CVS is 5656
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 8181
Overall Rank
The Sharpe Ratio Rank of ABBV is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 7575
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 7878
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 8888
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 8080
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CVS vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CVS Health Corporation (CVS) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CVS, currently valued at 0.10, compared to the broader market-2.00-1.000.001.002.003.00
CVS: 0.10
ABBV: 0.98
The chart of Sortino ratio for CVS, currently valued at 0.44, compared to the broader market-6.00-4.00-2.000.002.004.00
CVS: 0.44
ABBV: 1.35
The chart of Omega ratio for CVS, currently valued at 1.06, compared to the broader market0.501.001.502.00
CVS: 1.06
ABBV: 1.21
The chart of Calmar ratio for CVS, currently valued at 0.07, compared to the broader market0.001.002.003.004.005.00
CVS: 0.07
ABBV: 1.28
The chart of Martin ratio for CVS, currently valued at 0.34, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
CVS: 0.34
ABBV: 3.19

The current CVS Sharpe Ratio is 0.10, which is lower than the ABBV Sharpe Ratio of 0.98. The chart below compares the historical Sharpe Ratios of CVS and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
0.10
0.98
CVS
ABBV

Dividends

CVS vs. ABBV - Dividend Comparison

CVS's dividend yield for the trailing twelve months is around 3.94%, more than ABBV's 3.21% yield.


TTM20242023202220212020201920182017201620152014
CVS
CVS Health Corporation
3.94%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%1.14%
ABBV
AbbVie Inc.
3.21%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

CVS vs. ABBV - Drawdown Comparison

The maximum CVS drawdown since its inception was -64.07%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for CVS and ABBV. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-31.88%
-7.55%
CVS
ABBV

Volatility

CVS vs. ABBV - Volatility Comparison

The current volatility for CVS Health Corporation (CVS) is 11.90%, while AbbVie Inc. (ABBV) has a volatility of 13.36%. This indicates that CVS experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%December2025FebruaryMarchAprilMay
11.90%
13.36%
CVS
ABBV

Financials

CVS vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between CVS Health Corporation and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20212022202320242025
94.59B
13.34B
(CVS) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

CVS vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between CVS Health Corporation and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20212022202320242025
15.2%
100.0%
(CVS) Gross Margin
(ABBV) Gross Margin
CVS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, CVS Health Corporation reported a gross profit of 14.40B and revenue of 94.59B. Therefore, the gross margin over that period was 15.2%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 13.34B and revenue of 13.34B. Therefore, the gross margin over that period was 100.0%.
CVS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, CVS Health Corporation reported an operating income of 3.37B and revenue of 94.59B, resulting in an operating margin of 3.6%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
CVS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, CVS Health Corporation reported a net income of 1.78B and revenue of 94.59B, resulting in a net margin of 1.9%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.